New hope for skin allergy sufferers: dupilumab under study
NCT ID NCT03935971
First seen Feb 28, 2026 · Last updated May 13, 2026 · Updated 9 times
Summary
This study looks at whether dupilumab can help people with allergic contact dermatitis, a skin reaction caused by contact with allergens. Seventeen adults with confirmed allergies will receive the drug and be monitored for skin clearance and symptom changes. The goal is to see if dupilumab reduces the severity and spread of the rash.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC CONTACT DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital, Department of Dermatology
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.